FDA Inspection 1235545 - Boehringer Ingelheim Pharmaceuticals, Inc. - May 02, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Boehringer Ingelheim Pharmaceuticals, Inc.

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Pharmaceuticals, Inc., with an inspection on May 2, 2024, issued by the New England District Office, covering biologics.

Company: Boehringer Ingelheim Pharmaceuticals, Inc.
Inspection Date: May 2, 2024
Product Type: Biologics
Office: New England District Office

Open in Dashboard

ID · 122bc596-1442-42ff-ae7f-bbbed8bd1ff0